Simulations Plus Gross Profit 2010-2024 | SLP
Simulations Plus gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Simulations Plus Annual Gross Profit
(Millions of US $) |
| 2024 |
$43 |
| 2023 |
$48 |
| 2022 |
$43 |
| 2021 |
$36 |
| 2020 |
$31 |
| 2019 |
$25 |
| 2018 |
$22 |
| 2017 |
$18 |
| 2016 |
$15 |
| 2015 |
$14 |
| 2014 |
$10 |
| 2013 |
$8 |
| 2012 |
$8 |
| 2011 |
$7 |
| 2010 |
$8 |
| 2009 |
$7 |
Simulations Plus Quarterly Gross Profit
(Millions of US $) |
| 2024-11-30 |
$10 |
| 2024-08-31 |
$7 |
| 2024-05-31 |
$13 |
| 2024-02-29 |
$13 |
| 2023-11-30 |
$10 |
| 2023-08-31 |
$12 |
| 2023-05-31 |
$13 |
| 2023-02-28 |
$13 |
| 2022-11-30 |
$9 |
| 2022-08-31 |
$9 |
| 2022-05-31 |
$12 |
| 2022-02-28 |
$12 |
| 2021-11-30 |
$10 |
| 2021-08-31 |
$7 |
| 2021-05-31 |
$10 |
| 2021-02-28 |
$10 |
| 2020-11-30 |
$8 |
| 2020-08-31 |
$7 |
| 2020-05-31 |
$10 |
| 2020-02-29 |
$8 |
| 2019-11-30 |
$7 |
| 2019-08-31 |
$6 |
| 2019-05-31 |
$8 |
| 2019-02-28 |
$6 |
| 2018-11-30 |
$5 |
| 2018-08-31 |
$5 |
| 2018-05-31 |
$7 |
| 2018-02-28 |
$5 |
| 2017-11-30 |
$5 |
| 2017-08-31 |
$4 |
| 2017-05-31 |
$5 |
| 2017-02-28 |
$4 |
| 2016-11-30 |
$4 |
| 2016-08-31 |
$3 |
| 2016-05-31 |
$5 |
| 2016-02-29 |
$4 |
| 2015-11-30 |
$4 |
| 2015-08-31 |
$3 |
| 2015-05-31 |
$5 |
| 2015-02-28 |
$3 |
| 2014-11-30 |
$3 |
| 2014-08-31 |
$2 |
| 2014-05-31 |
$4 |
| 2014-02-28 |
$3 |
| 2013-11-30 |
$2 |
| 2013-08-31 |
$1 |
| 2013-05-31 |
$3 |
| 2013-02-28 |
$3 |
| 2012-11-30 |
$2 |
| 2012-08-31 |
$1 |
| 2012-05-31 |
$2 |
| 2012-02-29 |
$2 |
| 2011-11-30 |
$2 |
| 2011-08-31 |
$2 |
| 2011-05-31 |
$2 |
| 2011-02-28 |
$2 |
| 2010-11-30 |
$2 |
| 2010-08-31 |
$2 |
| 2010-05-31 |
$2 |
| 2010-02-28 |
$2 |
| 2009-11-30 |
$2 |
| 2009-08-31 |
$1 |
| 2009-05-31 |
$2 |
| 2009-02-28 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.662B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
